newsfilter
← Latest News
ACCESS Newswire·

MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results

Monjuvi U.S. net product sales of US$ 22.0 million (€ 18.6 million), 22% growth Q-Q Ten abstracts, including two oral presentations, accepted at upcoming ASH Pelabresib data for arm 3 of MANIFEST study to be presented at ASH confirm prior data Felz